经对侧股静脉/同侧胫静脉入路行药物机械性血栓清除术治疗全肢急性深静脉血栓的临床疗效
本回顾性队列研究比较了经对侧股静脉或同侧胫静脉入路(CFVA/ITVA)与经同侧腘静脉入路(IPVA)行药物机械性血栓清除术(PMT)治疗全肢急性深静脉血栓(DVT)的早期结果。共纳入73例患者(CFVA/ITVA组37例,IPVA组36例)。
要点
- CFVA/ITVA入路行PMT较传统IPVA入路血栓清除III级比例更高。
- CFVA/ITVA入路可降低全肢急性DVT患者PTS发生率。
- 血栓清除分级和入路类型是PTS发生的独立影响因素。
核心结论
- 采用CFVA/ITVA代替传统IPVA行PMT治疗全肢急性DVT,可提高血栓清除率、减少后续导管 directed 溶栓需求,并可能降低PTS发生率。
研究设计与样本
- 回顾性队列研究,纳入2016年1月至2019年3月两家独立血管中心接受PMT的全肢急性DVT患者共73例,其中CFVA/ITVA组37例,IPVA组36例。
主要发现
- 血栓清除分级和入路类型是PTS发生的独立影响因素。
- 实现完全血栓清除(III级)且采用CFVA/ITVA的患者PTS发生率显著更低。
临床怎么用
- 在治疗全肢急性DVT时,可优先考虑经对侧股静脉或同侧胫静脉入路行PMT,以提高血栓清除效果并减少PTS风险。
局限性
- 本研究为回顾性队列研究,样本量有限(共73例),且两家中心采用不同入路,可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: In the present study, we compared the early results between different approaches for pharmacomechanical thrombectomy (PMT) in the treatment of entire-limb acute deep vein thrombosis (DVT). METHODS: The present retrospective cohort study included patients with entire-limb acute DVT who had undergone PMT from January 2016 to March 2019 at two independent vascular centers. At the first center (Renji Hospital), the vascular surgeons used contralateral femoral venous access or ipsilateral tibial venous access (CFVA/ITVA). All consecutive patients with entire-limb acute DVT had undergone PMT through CFVA/ITVA at the first center. At the second center (Affiliated Hangzhou First People's Hospital), the vascular surgeons had conducted PMT using the traditional approach via ipsilateral popliteal venous access (IPVA). All consecutive patients had undergone PMT through IPVA at the second center. The primary endpoint was the incidence of post-thrombotic syndrome (PTS). The secondary endpoints included thrombus removal grade, venous primary patency rate, and the incidence of moderate-to-severe PTS. RESULTS: A total of 73 patients were enrolled in the present study, including 37 patients with CFVA/ITVA at the first center and 36 patients with IPVA at the second center. No significant difference was detected between the two groups in age, gender, onset time, affected limb, or risk factors. The proportion of patients who had undergone catheter-directed thrombolysis was significantly lower in the CFVA/ITVA group than in the IPVA group (P = .010). Thrombus removal grade III was achieved more often in the CFVA/ITVA group than in the IPVA group (P = .007). The PTS incidence was significantly lower in the CFVA/ITVA group than in the IPVA group (P = .043). The thrombus removal grade and access type were independent factors associated with the development of PTS. Patients with complete thrombus removal (grade III) and CFVA/ITVA had a significantly lower incidence of PTS. CONCLUSIONS: PMT can increase the thrombus clearance rate, reduce the requirement for subsequent catheter-directed thrombolysis, and, potentially, decrease the incidence of PTS using CFVA/ITVA instead of traditional IPVA in the treatment of entire-limb acute DVT.
引用
- Ni Q, Long J, Guo X, et al. Clinical efficacy of one-stage thrombus removal via contralateral femoral and ipsilateral tibial venous access for pharmacomechanical thrombectomy in entire-limb acute deep vein thrombosis. J Vasc Surg Venous Lymphat Disord. 2021. PMID: 33540135. doi:10.1016/j.jvsv.2021.01.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。